The FDA may not agree to a new clinical trial in a

The FDA may not agree to a new clinical trial in any indication until the safety hold is lifted. Since Cytodyn wants to do a pre-clinical for NASH now would be a good time to do it since it would not be affected by a safety hold. They may have already started along that pathway but we might not know it until they release data.